12.4 Targeted Temperature Management After Cardiac Arrest
Key Takeaways
- The 2023 AHA focused update on adult ACLS renamed targeted temperature management as temperature control: all adults who do not follow commands after ROSC, regardless of arrest location or initial rhythm, should receive a deliberate temperature control strategy (Class 1, LOE B-R).
- Select and maintain a constant temperature anywhere between 32 and 37.5 degrees C (Class 1, LOE B-R) and hold it for at least 24 hours (Class 2a) - cooling every patient to 33 degrees C is no longer the standard.
- Rapid infusion of cold intravenous fluid for prehospital cooling is not recommended (Class 3, No Benefit), and spontaneously hypothermic unresponsive patients should not be rewarmed faster than about 0.5 degrees C per hour.
- Shivering defeats the therapy: score it with the Bedside Shivering Assessment Scale (0-3, goal 0-1) and escalate stepwise through counterwarming, acetaminophen, magnesium, buspirone, opioids, dexmedetomidine and propofol, using neuromuscular blockade only with adequate sedation.
- Potassium shifts intracellularly during cooling and rebounds out during rewarming, so replacement given late in the maintenance phase can produce dangerous hyperkalemia - stop supplementation before rewarming begins and rewarm at 0.25-0.5 degrees C per hour.
What Changed, and Why It Matters for the Exam
A CMC candidate who studied from older material will answer temperature questions wrong. The teaching that every comatose survivor of ventricular fibrillation arrest is cooled to 32-34 degrees C is retired.
The 2023 American Heart Association Focused Update on Adult Advanced Cardiovascular Life Support, published in Circulation in 2024, deliberately renamed the intervention from targeted temperature management to temperature control and set the following recommendations:
| Recommendation | Class / LOE |
|---|---|
| All adults who do not follow commands after ROSC, irrespective of arrest location or presenting rhythm, receive treatment that includes a deliberate strategy for temperature control | Class 1, LOE B-R |
| Select and maintain a constant temperature between 32 and 37.5 degrees C during post-arrest temperature control | Class 1, LOE B-R |
| Maintain the selected target for at least 24 hours after achieving it | Class 2a, LOE B-NR |
| Actively prevent fever in patients who remain unresponsive after the initial temperature control period | Class 2b, LOE C-LD |
| Do not routinely rewarm spontaneously hypothermic unresponsive post-ROSC patients faster than 0.5 degrees C per hour | Class 2b, LOE C-EO |
| Do not routinely use rapid infusion of cold intravenous fluid for prehospital cooling after ROSC | Class 3 (No Benefit), LOE B-R |
The Trial History Behind the Change
- HACA and Bernard (2002) - two small trials in out-of-hospital ventricular fibrillation arrest showed improved neurologic outcome with 12-24 hours of cooling to 32-34 degrees C. These created the therapeutic hypothermia era.
- TTM1 (2013) - 950 patients randomized to a target of 33 versus 36 degrees C found no difference in mortality or neurologic outcome. The reading was that active temperature control mattered and that 33 was not superior to 36.
- TTM2 (2021) - 1,850 patients randomized to hypothermia at 33 degrees C versus normothermia with active fever prevention (treat if temperature reaches 37.8) again found no difference in 6-month mortality or functional outcome, with more arrhythmia causing hemodynamic compromise in the hypothermia arm.
The guideline widened the acceptable range to 32-37.5 degrees C precisely because the trials could not show one target beating another - while continuing to require that a target be chosen deliberately and held, because fever after arrest is consistently associated with worse neurologic outcome. The practical upshot at the bedside: institutions differ, many now default to 36 or 37 degrees C, and lower targets are still used selectively. The nurse's job is not to argue the number but to hold whichever number is prescribed without drift.
Why Temperature Control at All: Post-Cardiac-Arrest Syndrome
After return of spontaneous circulation (ROSC) four processes run in parallel and drive the mortality that follows a technically successful resuscitation:
- Anoxic brain injury - excitotoxicity, calcium influx, free radical generation, mitochondrial failure, and delayed apoptosis over hours to days; loss of cerebral autoregulation makes the brain pressure-passive and vulnerable to both hypotension and hyperoxia.
- Post-arrest myocardial dysfunction - global stunning with a depressed ejection fraction that typically nadirs at 8-24 hours and recovers over 48-72 hours; commonly needs inotropic support and is reversible.
- Systemic ischemia-reperfusion response - a sepsis-like state with vasoplegia, capillary leak, coagulation activation, adrenal suppression, and rising lactate.
- Persistent precipitating pathology - the acute coronary occlusion, pulmonary embolism, hemorrhage, electrolyte disorder, or toxin that caused the arrest and still needs treating.
Temperature control lowers cerebral metabolic rate (roughly 6-8% per degree C), reduces excitotoxicity, inflammation, and free radical production, and above all prevents the fever that worsens all of it.
A 61-year-old is 26 hours post out-of-hospital ventricular fibrillation arrest, maintained at 33 degrees C, and rewarming has begun at 0.25 degrees C per hour. Potassium was 3.1 mEq/L six hours ago and an infusion of potassium chloride was running until 30 minutes ago. The monitor now shows peaked T waves with a widening QRS, and the potassium is 6.1 mEq/L. What is the most likely explanation?
Delivering Temperature Control: Phases and Devices
Devices
Surface cooling uses adhesive hydrogel pads or circulating-water blankets with a servo feedback loop to a core temperature probe. It is fast to apply, non-invasive, and adequate for most patients, but skin injury under the pads is a real risk and temperature control is slightly less precise. Intravascular (endovascular) cooling uses a central catheter with a closed saline-circulating balloon; it delivers the tightest control with the least overshoot, but adds a large central line with its infection and thrombosis risk. Simple adjuncts - ice packs to groin and axillae, cooled ambient air, antipyretics - are inadequate alone for a controlled protocol. Rapid infusion of cold intravenous fluid is specifically not recommended for prehospital cooling (it increased pulmonary edema and re-arrest without benefit) though chilled fluid may still be used in hospital as an adjunct during induction in selected patients.
Core Temperature Measurement
The protocol is only as good as the probe. Use a continuous core site with servo feedback:
| Site | Reliability | Caveats |
|---|---|---|
| Pulmonary artery catheter | Reference standard | Only available if a PA catheter is already indicated |
| Esophageal | Excellent, fast-responding | Must be positioned in the lower third of the esophagus; displacement or gastric lavage distorts readings |
| Bladder | Good, widely used | Lags with low urine output - in oliguria or anuria the bladder probe underreports change and cannot be trusted during induction or rewarming |
| Rectal | Acceptable | Lags behind core changes; affected by stool |
| Temporal, tympanic, axillary, oral | Not acceptable for protocol management | Too inaccurate and too slow |
Use a second independent site for cross-checking. A sudden discrepancy is a probe problem until proven otherwise.
The Four Phases
| Phase | Goal | Nursing focus |
|---|---|---|
| Induction | Reach the selected target promptly | Start early, sedate and control shivering before the temperature drops, secure the probe, anticipate hypotension and bradycardia, watch potassium fall |
| Maintenance (at least 24 hours) | Hold the target with minimal drift | Avoid overshoot below the target; hourly temperature documentation; shivering scoring; potassium and glucose surveillance; sedation depth; skin checks under pads |
| Rewarming | Return to normothermia slowly | 0.25-0.5 degrees C per hour - the highest-risk phase; anticipate vasodilation and hypotension, rebound hyperkalemia, falling insulin requirement and hypoglycemia, and rising intracranial pressure in the injured brain |
| Normothermia / fever prevention | Prevent fever for at least 72 hours | Keep the device on with a normothermia set point rather than removing it; treat any temperature above 37.5-37.8 degrees C actively; investigate fever as infection as well as neurogenic |
Overshoot is a genuine safety event: passively drifting to 31 degrees C during induction increases arrhythmia, coagulopathy, and infection risk without added benefit. Servo-controlled devices exist to prevent it - never manage a protocol with manual ice alone.
Shivering: The Central Nursing Problem
Shivering is a normal thermoregulatory defense that begins near a threshold of 35.5 degrees C and it defeats the therapy: it rewarms the patient against the device, raises the metabolic rate and oxygen consumption by up to 40-100%, raises myocardial oxygen demand and heart rate in a patient who just had an arrest, raises intracranial pressure, and causes patient distress.
Score it with the Bedside Shivering Assessment Scale (BSAS) every 1-4 hours and with every intervention:
| BSAS | Finding |
|---|---|
| 0 | None - no shivering on palpation of the masseter, neck, or chest wall |
| 1 | Mild - shivering localized to the neck and thorax only |
| 2 | Moderate - intermittent involvement of the upper extremities in addition to neck and thorax |
| 3 | Severe - generalized shivering including trunk and all four extremities |
Target BSAS 0-1. Palpate the jaw and chest wall; in a sedated or paralyzed patient the visible signs disappear before the metabolic cost does, which is exactly why neuromuscular blockade without adequate sedation is dangerous and why a rising oxygen consumption or unexplained temperature drift signals hidden shivering.
The Anti-Shivering Ladder
| Step | Intervention | Adult dosing and notes |
|---|---|---|
| 1 | Surface counterwarming | Warm air to face, hands, feet; raises the shivering threshold with essentially no side effects and should be running from the start |
| 2 | Acetaminophen | 650-1,000 mg every 4-6 hours (maximum 4 g/day, less in hepatic disease) |
| 3 | Magnesium sulfate | Infusion targeting a serum level of about 3-4 mg/dL; lowers the shivering threshold and is antiarrhythmic |
| 4 | Buspirone | 30 mg every 8 hours enterally; synergistic with opioids and magnesium |
| 5 | Opioids | Fentanyl infusion; meperidine 12.5-25 mg IV is highly effective at the shivering threshold but accumulates as normeperidine and lowers the seizure threshold - use cautiously and avoid in renal failure |
| 6 | Dexmedetomidine | 0.2-1.4 mcg/kg/h; effective anti-shivering agent but causes bradycardia and hypotension, which compound the bradycardia of hypothermia |
| 7 | Propofol | 5-50 mcg/kg/min; deepens sedation and suppresses shivering; vasodilates and is negatively inotropic |
| 8 | Neuromuscular blockade | Bolus or infusion (for example cisatracurium) only with deep sedation and analgesia confirmed; use train-of-four monitoring, and remember it masks seizures - continuous EEG is advisable when a paralytic is running |
Work up the ladder rather than jumping to paralysis; paralytics abolish the visible sign, prolong ventilation, and may delay neurologic assessment.
A patient is being maintained at 33 degrees C after cardiac arrest. The Bedside Shivering Assessment Scale score has risen to 2, the patient is receiving acetaminophen and surface counterwarming, the RASS is -3 on a fentanyl and propofol infusion, and the core temperature has drifted from 33.0 to 33.6 degrees C despite maximal device output. What is the most appropriate next step?
Physiologic Effects to Anticipate and Manage
| System | Effect during cooling | Nursing response |
|---|---|---|
| Cardiac | Bradycardia (sinus rates of 40-50/min are common and expected), prolonged PR, QRS and QTc, Osborn (J) waves below about 32 degrees C, reduced contractility with preserved or increased systemic vascular resistance | Treat bradycardia only if perfusion is inadequate - a slow rate with an adequate mean arterial pressure and lactate clearance is acceptable and is not an indication for pacing or atropine; hypothermic bradycardia is often resistant to atropine |
| Renal / volume | Cold diuresis from reduced ADH and increased venous return produces hypovolemia hours into cooling | Anticipate volume replacement, track urine output hourly, do not misread the diuresis as recovering renal function |
| Electrolytes | Potassium, magnesium and phosphate shift intracellularly during cooling and shift back out during rewarming | Replace conservatively (potassium goal 3.0-3.5 mEq/L during maintenance), stop supplementation before rewarming, recheck every 2-4 hours through rewarming |
| Glucose | Insulin resistance and reduced insulin secretion cause hyperglycemia during cooling; insulin sensitivity returns during rewarming | Target roughly 140-180 mg/dL, avoid hypoglycemia, and reduce the insulin infusion as rewarming begins |
| Coagulation | Impaired platelet function and slowed enzymatic clotting; standard coagulation assays are run at 37 degrees C and therefore underestimate the real coagulopathy | Monitor for bleeding, especially after coronary intervention with dual antiplatelet therapy and anticoagulation; this is a real consideration in the post-arrest patient taken to the catheterization laboratory |
| Drug handling | Reduced hepatic and renal clearance prolongs sedatives, analgesics, and neuromuscular blockers; propofol and midazolam levels rise substantially | Anticipate delayed awakening and account for it in neuroprognostication; use the lowest effective sedation |
| Immune / infection | Leukocyte function is impaired and fever is masked | Maintain strict line and ventilator-bundle practice; a normal temperature does not exclude infection |
| Skin | Vasoconstriction plus pressure from cooling pads | Inspect under pads at least every 4-8 hours per device instructions, offload heels and bony prominences, turn as tolerated |
Concurrent Post-Arrest Management
Temperature control is one element of a bundle, and the exam expects the rest of it:
- Coronary angiography: emergent angiography for post-arrest patients with ST-elevation on the post-ROSC ECG. For stable patients without ST-elevation, current evidence (COACT, TOMAHAWK) does not support routinely rushing to the catheterization laboratory - angiography can be deferred and individualized based on hemodynamics, shock, and suspicion of an ongoing occlusion.
- Hemodynamic targets: avoid hypotension; maintain a mean arterial pressure above 65-80 mmHg (a higher mean is often targeted because cerebral autoregulation is lost and cerebral perfusion becomes pressure-passive). Expect post-arrest myocardial stunning that may need inotropes and, in refractory shock, mechanical support.
- Oxygenation and ventilation: titrate FiO2 to an SpO2 of 92-98% and avoid both hypoxemia and hyperoxia; target normocapnia (PaCO2 35-45 mmHg) and specifically avoid hypocapnia, which vasoconstricts cerebral vessels and worsens ischemia.
- Seizures: non-convulsive seizures and status epilepticus are common and invisible in a sedated or paralyzed patient. Obtain EEG promptly and use continuous EEG when the patient is paralyzed or has myoclonus; treat seizures, and recognize that myoclonus alone is not a reliable prognostic sign.
- Glucose, nutrition, and prophylaxis: glucose 140-180 mg/dL, early enteral nutrition at trophic rates during hypothermia (gastric motility is slowed), venous thromboembolism prophylaxis balanced against bleeding risk.
Neuroprognostication
The rule that gets tested: defer definitive neuroprognostication until at least 72 hours after return to normothermia, and longer if sedation, paralysis, hypothermia, renal or hepatic dysfunction, or hemodynamic instability could be confounding the examination. Never base a withdrawal-of-life-sustaining-therapy conversation on a single finding.
Use multimodal assessment: serial clinical examination (bilaterally absent pupillary light reflex and corneal reflexes, motor response no better than extension), status myoclonus within 72 hours, EEG (burst suppression with identical bursts, suppressed background, status epilepticus), bilaterally absent N20 somatosensory evoked potentials, markedly elevated and rising neuron-specific enolase, and imaging (loss of grey-white differentiation with a reduced grey-white ratio on CT, or diffuse restricted diffusion on MRI). The nurse's contribution is disciplined, documented serial neurologic examinations off sedation when feasible, accurate reporting of sedation and paralytic timing, and honest, consistent communication with the family that early appearances are not the final answer.
A patient is 30 hours post cardiac arrest, has completed 24 hours at a target of 36 degrees C, and is now normothermic. Propofol and fentanyl infusions were stopped 2 hours ago. The pupillary light reflex is sluggish, the motor response is extension to pain, and the family asks the nurse whether the patient will ever wake up. What is the most appropriate nursing response and plan?